Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meijerink

Showing results (671-680 of 749) with videos related to

Pageof 75
Sort By:
Blood|July 19, 2021
BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathwayMiriam Butler, Dorette S van Ingen Schenau, Jiangyan Yu, et al.
Haematologica|September 8, 2006
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocolsMartine van Grotel, Jules P P Meijerink, H Berna Beverloo, et al.
Lancet (London, England)|June 26, 2018
Personalised perioperative care by e-health after intermediate-grade abdominal surgery: a multicentre, single-blind, randomised, placebo-controlled trialEva van der Meij, Johannes R Anema, Wouter K G Leclercq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predispositionTomasz Szczepanski, Vincent H J van der Velden, Esmé Waanders, et al.
Cancers|March 28, 2024
The Added Value of Transcatheter CT Hepatic Angiography (CTHA) Image Guidance in Percutaneous Thermal Liver Ablation: An Experts' Opinion Pictorial EssayRobbert S Puijk, Madelon Dijkstra, Susan van der Lei, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2017
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based studyKoen P Rovers, Geert A Simkens, Pauline A Vissers, et al.
BMJ Open|July 8, 2026
(Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trialLauren P W Te Molder, J P Michiel Sedelaar, Joyce G R Bomers, et al.
Cancers|August 26, 2022
Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary InvolvementEmma Kroeze, Laura Arias Padilla, Max Bakker, et al.
Blood|October 11, 2014
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemiaSofie Peirs, Filip Matthijssens, Steven Goossens, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 5, 2024
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023Mario Fontán-Vela, Esther Kissling, Nathalie Nicolay, et al.
Pageof 75

Showing results (671-680 of 749) with videos related to

Sort By:
Pageof 75
Blood|July 19, 2021
BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathwayMiriam Butler, Dorette S van Ingen Schenau, Jiangyan Yu, et al.
Haematologica|September 8, 2006
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocolsMartine van Grotel, Jules P P Meijerink, H Berna Beverloo, et al.
Lancet (London, England)|June 26, 2018
Personalised perioperative care by e-health after intermediate-grade abdominal surgery: a multicentre, single-blind, randomised, placebo-controlled trialEva van der Meij, Johannes R Anema, Wouter K G Leclercq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predispositionTomasz Szczepanski, Vincent H J van der Velden, Esmé Waanders, et al.
Cancers|March 28, 2024
The Added Value of Transcatheter CT Hepatic Angiography (CTHA) Image Guidance in Percutaneous Thermal Liver Ablation: An Experts' Opinion Pictorial EssayRobbert S Puijk, Madelon Dijkstra, Susan van der Lei, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2017
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based studyKoen P Rovers, Geert A Simkens, Pauline A Vissers, et al.
BMJ Open|July 8, 2026
(Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trialLauren P W Te Molder, J P Michiel Sedelaar, Joyce G R Bomers, et al.
Cancers|August 26, 2022
Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary InvolvementEmma Kroeze, Laura Arias Padilla, Max Bakker, et al.
Blood|October 11, 2014
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemiaSofie Peirs, Filip Matthijssens, Steven Goossens, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 5, 2024
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023Mario Fontán-Vela, Esther Kissling, Nathalie Nicolay, et al.
Pageof 75